Ruti Aga Handed Six-Year Ban: A Family Member's Forged Prescription Seals Her Career

Ethiopian marathon runner Ruti Aga has been banned for six years by the Athletics Integrity Unit (AIU), in a sanction built from two separate violations: the presence of the prohibited substance methylprednisolone in a sample taken at a half marathon she won in China in March, and the submission of a forged medical prescription during the investigation — a document written by a family member who held no medical registration. The AIU confirmed both violations in a statement issued on Thursday. Two years for the presence violation, four years for tampering. Six in total. The ban runs from 10 September, the same date her provisional suspension began. Technically this is a procedural benefit, since provisional suspension time counts against the sanction; in practice it gives the athlete nothing, because the clock had already started running. At 32, the sanction removes her from the sport until roughly the age of 38. One technical correction must be made immediately, because several reports have described methylprednisolone as a prohibited steroid. It is not. Methylprednisolone is a glucocorticoid, class S9 on the WADA Prohibited List — not an anabolic steroid (S1). Under the current List, S9 glucocorticoids are prohibited in-competition only, and only when administered by injection, orally or rectally. A therapeutic knee injection given out of competition is entirely legal; it becomes a violation only if residues are present in an in-competition sample. That is the legal hinge of the entire case. The question was never whether the substance was a steroid, but by which route, in what dose and how many days before competition it was administered. An athlete with genuine medical records and correct washout timing could have defended the charge — either by holding a Therapeutic Use Exemption or by waiting out the required period before racing. Aga chose neither path. She chose a third: manufacturing the paperwork. According to the AIU statement, the prescription failed verification at three independent levels. First, the clinic named on the document did not exist. Second, the person who wrote it was not a registered physician but a family member. Third, that person claimed to have used an old prescription pad from a former workplace — and the institution in question explicitly disowned the claim. Three separate verification failures made it straightforward for investigators to establish that the document was fabricated. The arithmetic of the sanction deserves attention. The two-year term corresponds to the presence violation — the standard level for a substance the Code classifies as Specified and where intent was not established. The four-year term corresponds to tampering, the standard sanction under the World Anti-Doping Code. Together they make six. The arithmetic tells us something specific: the panel rejected the no-significant-fault mitigation that would otherwise have reduced the presence sanction. In other words, the forged document destroyed the very defence that might have worked. Aga's record before this decision was genuinely elite. She won the 2026 Tokyo Marathon, a World Marathon Major title, and finished second at Berlin in 2026. She has three second-place finishes at World Marathon Majors in total. Her personal best is widely reported as about 2:18:34, set in Berlin in 2026, although that figure does not appear in the AIU statement and should be independently verified. No time, split or field quality has been disclosed for the Chinese half marathon in March where the sample was collected, so no assessment of that performance is possible. The only known fact is that she won it. At 32, an athlete is at late peak or the beginning of decline. A six-year ban removes her entirely from the 2028 Olympic cycle. Ethiopia's depth in women's marathoning is so extreme that a 38-year-old returnee carrying a doping record is effectively unselectable for the national team. In career terms, a six-year sanction functions as a lifetime ban. The root cause, however, is not the substance — it is the knee. Aga's defence cited a knee injury for which the medication was taken. Intra-articular or peri-articular glucocorticoid injection for knee synovitis is standard sports-medicine practice in distance runners, so the clinical explanation is plausible. And that plausibility is precisely why the forgery proved decisive: a genuine treatment would have been defended with genuine records. This is where an individual error becomes a system failure. An athlete competing at world level should have had a credentialed team physician beside her. The AIU facts suggest her medical support was informal — so informal that a family member was writing the prescription. This is not an isolated case in East African road-racing entourages but a recognisable pattern: talent, training and agent structures are professional, while medical governance is not. There is an economic layer too. China's label-race circuit is an attractive, low-risk income tier for East African marathoners between Majors — decent appearance fees, manageable fields. The same circuit has become one of the AIU's highest-yield testing grounds. The appearance-fee economy and the testing economy are colliding in the same races. Under standard AIU practice, the March result, its prize money and any ranking points accrued afterwards would be annulled, even though the statement does not spell this out. The competitive landscape is essentially unaffected. Ethiopia's women's marathon depth operates at world-record level; the removal of one 32-year-old with no global championship medals and three Major second places does not move national medal capacity by any measurable margin. Kenya and Ethiopia are both structurally deep and both structurally exposed to entourage-level governance failure. What is shifting is the enforcement frontier. AIU road-racing cases once centred on detection; they now increasingly centre on document verification. Aga's case is not an outlier — it belongs to a family of East African road-racing cases in which an initial substance violation is compounded by a fabricated explanation, roughly doubling the sanction. A notable technical detail: the four-year tampering charge arose not only from a document but from statements made in interview — and language and translation conditions in AIU interviews with non-English-speaking athletes have been a recurring source of dispute. The legal route is not entirely closed. An appeal to the Court of Arbitration for Sport is typically available for about 21 days from receipt of the reasoned decision. But findings of document forgery are hard to overturn, so both the prospects and the practical value of such an appeal are low. Document forgery also carries a criminal dimension outside the AIU's jurisdiction, which could be referred to national authorities — whether any such step has been taken is not stated. Ultimately the lesson of this case lies in governance, not pharmacology. A substance with no proven endurance benefit produced a six-year ban — but the weight of that sanction was carried not by the substance, but by the paper. Had Aga held a single valid medical record, the case might never have begun, or at least would not have ended at six years. That is the hardest conclusion here: in the modern anti-doping system, you can survive the substance. You cannot survive the document.